Here's Why Investors Should Hold Onto Nabors Stock for Now

Nabors Industries (NBR) presents a mixed investment outlook, with its stock down 56.7% over the past year and grappling with persistent net losses and a substantial $2.7 billion debt burden, despite a recent $600 million divestment aimed at debt reduction. Positively, the company reported robust Q2 2025 revenues of $833 million, driven by strong international growth via the SANAD joint venture with Saudi Aramco, successful integration of the Parker Wellbore acquisition boosting EBITDA, and technological advancements. While the U.S. onshore market shows weakness and capital expenditures remain high, analysts project a significant narrowing of losses and revenue growth for 2025, leading to a 'hold' recommendation as investors await clearer execution on debt management and international expansion initiatives.

Analysis

Nabors Industries (NBR) presents a deeply bifurcated investment profile, where strategic growth initiatives are counteracted by significant financial pressures. Operationally, the company demonstrates strong momentum, with Q2 2025 revenues rising to $833 million from $735 million year-over-year, driven by its International Drilling and Drilling Solutions segments. The SANAD joint venture with Saudi Aramco provides a clear long-term growth catalyst with multi-year earnings visibility from new rig deployments. Furthermore, the March 2025 acquisition of Parker Wellbore is already accretive, boosting Drilling Solutions EBITDA to $76.5 million from $40.9 million in the prior quarter and tracking ahead of its $40 million synergy target. However, these positives are overshadowed by severe stock underperformance, with shares down 56.7% over the past year. The company remains unprofitable, posting an adjusted loss of $2.71 per share in Q2, and carries a heavy long-term debt load of $2.7 billion. While a recent $600 million divestiture is a positive step toward deleveraging, weakness persists in the core U.S. Lower 48 market, where daily gross margins fell to $13,900 and are projected to decline further to $13,300, lagging competitors like Helmerich & Payne. The company's capital-intensive strategy, with a 2025 capex guidance of $700-$710 million, further strains near-term cash flow, creating a high-risk, high-reward scenario dependent on flawless execution.

Key Decisions for Investors

• Investors should monitor management's execution on debt reduction following the $600 million asset sale, as progress on strengthening the balance sheet is critical to de-risking the equity story.
• Closely track the performance of the international segment, particularly the SANAD joint venture, as its growth and margin profile must successfully offset the forecasted margin compression and flat-to-down activity in the U.S. Lower 48 market.
• Evaluate the company's free cash flow generation in coming quarters, as the high capital expenditure of $700-$710 million for 2025 presents a significant hurdle that could strain liquidity if project returns or operational cash flows disappoint.
• Consider the stock's valuation in the context of its significant underperformance and consensus estimates for a 79.4% year-over-year improvement in loss per share, which suggests much of the negative news may be priced in, but a turnaround is contingent on resolving the aforementioned financial and operational challenges.